Zimmer Biomet Holdings Inc (NYSE:ZBH), a leading player in the medical devices sector with a market capitalization of $22.12 ...
Zimmer Biomet (NYSE:ZBH – Get Free Report)‘s stock had its “hold” rating reaffirmed by stock analysts at Needham & Company LLC in a research note issued to investors on Wednesday,Benzinga reports.
BTIG analyst Ryan Zimmerman has maintained their bullish stance on ZBH stock, giving a Buy rating on January 23.Invest with Confidence: Follow ...
Zimmer Biomet made a major play in the foot and ankle treatment space today, announcing it will spend $1.2 billion to acquire ...
In a report released today, Caitlin Cronin from Canaccord Genuity maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report), ...
Zimmer Biomet (NYSE:ZBH – Get Free Report) is anticipated to post its quarterly earnings results before the market opens on Thursday, February 6th. Analysts expect Zimmer Biomet to post earnings of $2 ...
Paragon 28, Inc. (NYSE:FNA) shares are trading higher premarket on Wednesday. On Tuesday, the company inked a deal to be ...
Investors in Zimmer Biomet Holdings Inc (Symbol: ZBH) saw new options begin trading today, for the March 2026 expiration. One of the key data points that goes into the price an option buyer is ...
Zimmer Biomet (NYSE:ZBH) to acquire Paragon 28 (NYSE:FNA) for approximately $1.1B to expand its portfolio in the orthopedic surgical device market. Paragon 28 is Colorado-based medical device company ...
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products ...
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Paragon 28, Inc. (NYSE: FNA), a leading medical device company focused exclusively on the foot and ankle ...
JP Morgan has recently raised Zimmer Biomet Holdings Inc (ZBH) stock to Overweight rating, as announced on December 17, 2024, according to Finviz. Earlier, on September 10, 2024, Wolfe Research had ...